Table of Contents Author Guidelines Submit a Manuscript
International Journal of Surgical Oncology
Volume 2012, Article ID 307670, 7 pages
http://dx.doi.org/10.1155/2012/307670
Research Article

Survival Benefit of Adjuvant Radiation Therapy for Gastric Cancer following Gastrectomy and Extended Lymphadenectomy

1Department of Surgery, Vanderbilt University Medical Center, Nashville, TN 37232, USA
2Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN 37232, USA
3Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, TN 37232, USA
4Vanderbilt Ingram Cancer Center, Nashville, TN 37232-6860, USA
5Division of Surgical Oncology, Vanderbilt University Medical Center, 597 Preston Research Building, Nashville, TN 37232, USA

Received 30 January 2012; Accepted 6 May 2012

Academic Editor: Lapo Bencini

Copyright © 2012 R. A. Snyder et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. D. Crew and A. I. Neugut, “Epidemiology of gastric cancer,” World Journal of Gastroenterology, vol. 12, no. 3, pp. 354–362, 2006. View at Google Scholar · View at Scopus
  2. S. F. K. C. Altekruse, M. Krapcho, N. Neyman et al., SEER Cancer Statistics Review, 1975–2007, National Cancer Institute, Bethesda, Md, USA, 2010.
  3. W. B. Al-Refaie, J. F. Tseng, G. Gay et al., “The impact of ethnicity on the presentation and prognosis of patients with gastric adenocarcinoma: results from the national cancer data base,” Cancer, vol. 113, no. 3, pp. 461–469, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. S. A. Hundahl, J. L. Phillips, and M. R. Menck, “The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy. Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the “ different disease” hypothesis,” Cancer, vol. 88, no. 4, pp. 921–932, 2000. View at Google Scholar
  5. H. J. Wanebo, B. J. Kennedy, J. Chmiel, G. Steele, D. Winchester, and R. Osteen, “Cancer of the stomach: a patient care study by the American College of Surgeons,” Annals of Surgery, vol. 218, no. 5, pp. 583–592, 1993. View at Google Scholar · View at Scopus
  6. I. Songun, H. Putter, E. M. Kranenbarg, M. Sasako, and C. J. H. van de Velde, “Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial,” The Lancet Oncology, vol. 11, no. 5, pp. 439–449, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. J. S. Macdonald, S. R. Smalley, J. Benedetti et al., “Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction,” The New England Journal of Medicine, vol. 345, no. 10, pp. 725–730, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Strauss, D. L. Hershman, D. Buono et al., “Use of adjuvant 5-fluorouracil and radiation therapy after gastric cancer resection among the elderly and impact on survival,” International Journal of Radiation Oncology Biology Physics, vol. 76, no. 5, pp. 1404–1412, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. S. A. Hundahl, J. S. Macdonald, J. Benedetti, and T. Fitzsimmons, “Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: the effect of undertreatment,” Annals of Surgical Oncology, vol. 9, no. 3, pp. 278–286, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. M. J. Hayat, N. Howlader, M. E. Reichman, and B. K. Edwards, “Cancer statistics, trends, and multiple primary cancer analyses from the surveillance, epidemiology, and end results (SEER) program,” Oncologist, vol. 12, no. 1, pp. 20–37, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Maruyama, P. Gunven, K. Okabayashi, M. Sasako, and T. Kinoshita, “Lymph node metastases of gastric cancer. General pattern in 1931 patients,” Annals of Surgery, vol. 210, no. 5, pp. 596–602, 1989. View at Google Scholar · View at Scopus
  12. K. Maruyama, K. Okabayashi, and T. Kinoshita, “Progress in gastric cancer surgery in Japan and its limits of radicality,” World Journal of Surgery, vol. 11, no. 4, pp. 418–425, 1987. View at Google Scholar · View at Scopus
  13. Y. Kodera, Y. Yamamura, A. Torii et al., “Postoperative staging of gastric carcinoma: a comparison between the UICC stage classification and the 12th edition of the Japanese general rules for gastric cancer study,” Scandinavian Journal of Gastroenterology, vol. 31, no. 5, pp. 476–480, 1996. View at Google Scholar · View at Scopus
  14. M. Sasako, P. McCullouch, T. Kinoshita, and K. Maruyama, “New method to evaluate the therapeutic value of lymph node dissection for gastric cancer,” British Journal of Surgery, vol. 82, no. 3, pp. 346–351, 1995. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Kodama, K. Sugimachi, and K. Soejima, “Evaluation of extensive lymph node dissection for carcinoma of the stomach,” World Journal of Surgery, vol. 5, no. 2, pp. 241–248, 1981. View at Google Scholar · View at Scopus
  16. J. J. Bonenkamp, J. Hermans, M. Sasako, and C. J. H. Van De Velde, “Extended lymph-node dissection for gastric cancer,” The New England Journal of Medicine, vol. 340, no. 12, pp. 908–914, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Cuschieri, S. Weeden, J. Fielding et al., “Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial,” British Journal of Cancer, vol. 79, no. 9-10, pp. 1522–1530, 1999. View at Google Scholar · View at Scopus
  18. H. H. Hartgritik, C. J. van de Velde, H. Putter et al., “Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial,” Journal of Clinical Oncology, vol. 22, no. 11, pp. 2069–2077, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. J. R. Siewert, K. Bottcher, J. D. Roder, R. Busch, P. Hermanek, and H. J. Meyer, “Prognostic relevance of systematic lymph node dissection in gastric carcinoma,” British Journal of Surgery, vol. 80, no. 8, pp. 1015–1018, 1993. View at Google Scholar · View at Scopus
  20. R. E. Schwarz and D. D. Smith, “Clinical impact of lymphadenectomy extent in resectable gastric cancer of advanced stage,” Annals of Surgical Oncology, vol. 14, no. 2, pp. 317–328, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. D. D. Smith, R. R. Schwarz, and R. E. Schwarz, “Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database,” Journal of Clinical Oncology, vol. 23, no. 28, pp. 7114–7124, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. NCCN, NCCN Clinical Practice Guidelines in Oncology: Gastric Cancer, National Comprehensive Cancer Network, version 2.2011 edition, 2011.
  23. T. Kajitani, “The general rules for the gastric cancer study in surgery and pathology—part I. Clinical classification,” Japanese Journal of Surgery, vol. 11, no. 2, pp. 127–139, 1981. View at Google Scholar · View at Scopus
  24. S. Kim, D. H. Lim, J. Lee et al., “An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach,” International Journal of Radiation Oncology Biology Physics, vol. 63, no. 5, pp. 1279–1285, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. D. Cunningham, W. H. Allum, S. P. Stenning et al., “Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer,” The New England Journal of Medicine, vol. 355, no. 1, pp. 11–20, 2006. View at Publisher · View at Google Scholar · View at Scopus